Criticality of Packaging for Pharmaceutical Drugs and Technological Advancements are Expected to Drive the Global Pharmaceutical Packaging Testing Equipment Market in the forecast period of 2019 -2026

Drivers: Global Pharmaceutical Packaging Testing Equipment Market

CRITICALITY OF PACKAGING FOR PHARMACEUTICAL DRUGS

Access full Report:- https://databridgemarketresearch.com/reports/global-pharmaceutical-packaging-testing-equipment-market/

The drug’s safety can be ensured by using the good packaging material such as glass, metals plastics according to the drug, which can be ensured when the packaging undergoes the testing such as vibration testing, moisture testing and many more. Improper packaging can lead to Healthcare Associated Infections (HAI), according to Centers for Disease Control and Prevention (CDC) in North Carolina 5.0% of all admissions in hospitals acquires HAIs during their stay in hospital causing 99,000 deaths each year costing around USD 124.0 million - USD 348.0 million each year. In 2015 1 out of 31 hospital patients has at least one healthcare-associated infection. There were an estimated 687,000 HAIs in U.S. acute care hospitals in 2015. About 72,000 hospital patients with HAIs died during their hospitalizations and around 3% of hospitalized patients had one or more HAI in the 2015 survey.

TECHNOLOGICAL ADVANCEMENTS

The pharmaceutical packaging industry is constantly seeing innovations such as blow fill seal (BFS) to capsules being formulated by titanium dioxide. New pharmaceutical products such as new biological drug formulations, prefilled syringe requires new and Ecoslide-RX s. Ecoslide-RX s is a sustainable compliance packaging from 100% recycled material, using unbleached paperboard and a clay-coated surface designed to house blister packaging with a minimum of unsustainable film and foil. Syreen prefilled syringe is made of cyclic olefin polymer (COP) Instead of glass, Overall packaging leads to reduction in weight and volume. Hence, technological advancements such as permeability testing using chromatography in the field of pharmaceutical packaging results in the growth of the pharmaceutical packaging testing equipment market as new packaging innovations such as glass, metals, automation in packaging required to be tested in order to ensure whether the safety standards are met or not.

MANDATORY GUIDELINES

There are certain healthcare associated infections which can act as a threat to patient safety. Improper packaging can also lead to Healthcare Associated Infections (HAI), according to ECDC (European Centre for Disease Prevention and Control), in 2014, 8.0% of total patients admitted in Intensive Care unit (ICU) are presented with one of the ICU-acquired healthcare associated infection.

  • In 2018, European Centre for Disease Prevention and Control projected in European totals of 8.9 million healthcare-associated infections were estimated to occur each year in hospitals and long-term care facilities. Hence there is increase in healthcare associated infections which might occur at hospitals and long-term care facilities each year in Europe.
  • In 2016, U.S. Department of Health and Human Services (HHS) launched National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination (HAI Action Plan) for the national acute care hospitals this new action plan is using data from 2015 as a baseline and will see results in a 5-year period from 2015 to 2020. This action plan has four phase and evaluation state so that prevention can be done for healthcare associated infections.

The criticality of the pharmaceutical packaging resulted in the mandatory guidelines by the government for packaging testing, leading to the growth of the pharmaceutical packaging testing equipment market.

Restraint:

SHORTAGE OF SKILLED PROFESSIONALS:

Pharmaceutical packaging testing equipment is very advanced and complex instruments used in pharmaceutical industry, which demands for an expert and skilled professional who can work on the instrument effectively. The proper usage of testing equipment requires expertise with relevant experience and knowledge of pharmaceutical packaging testing. Moreover, the selection of the tests and equipment plays a crucial role. Risks such as contamination of the drug, exposure to the external forces (such as moisture, gases) associated with pharmaceutical packaging equipment are too high. The lack of knowledge regarding the right choice of technique incurs several direct and indirect expenses. There is a need for highly skilled personnel for method development, and validation.

Opportunities:

AUTOMATION IN PHARMACEUTICAL PACKAGING TESTING EQUIPMENT:

A fully automated system can be used as material testing machine and robot handling system ensures reliability, cost effective testing of pharmaceutical packaging. The robots that are used in the pharmaceutical packaging testing industry to perform test associated with research, discovery and development.

  • For Instance, Pfeiffer Vacuum Gmbh (Germany) offer Model ME2 Packaging for Pressure Leak Testing. Model ME2 Packaging is a mass Extraction sensitive, robust and reliable testing technology that is having massive leak strain measurement for pouches, automated vacuum test circuit, uniquely designed for ultra-tight leak spec. It is designed for very large leak detection, for headspace of 0.4 cc and larger Stainless steel chamber.

The application of packaging robots in the packaging industry ranges from moving fluids between wells in a plate, preparing DNA samples to picking up test tubes and loading them to the nuclear magnetic resonance imaging magnet. With the constant evolution in the technology, there would be advancement in the robotic technology which will fuel the growth of packaging testing equipment industry.

GROWING PHARMACEUTICAL INDUSTRY:

The pharmaceutical drug packaging testing equipment market is depends upon the growth of the pharmaceutical drugs market. In accordance with this trend, the remote and virtual healthcare industries are anticipated to benefit from this growth. The pharmaceutical device industry in the developed geographies is also undergoing strategic change as the industry is shifting more towards the prevention of the disease

  • In 2017 International Federation of Pharmaceutical Manufacturers & Associations projected that global pharmaceutical market will reach nearly USD 1,430.00 billion by 2020 and Countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. United States share of the global market will increase from 40.3% in 2015 to 41% in 2020.
  • In (2015), according to United Nations World Population Prospects: the 2015 Revision, between 2015 and 2030, the number of people aged 60 years or over is projected to grow by 56.0% and the increase in the old age population will lead to more and more number of pharmaceutical companies as old aged people requires more medication, it would lead to more concentration on safety packaging of the pharmaceutical devices and drugs thus resulting into the growth of pharmaceutical packaging testing equipment market.

The above statistics clearly states that the growth of pharmaceutical drugs packaging testing equipment market directly depends upon the demand in pharmaceutical drugs since the packaging of drug testing is done mainly for the pharmaceutical drugs.

Challenge:

TESTING ISSUES

With the growing pharmaceutical packaging industry, the complexity and issues related to the packaging testing is also growing. Many a times there arises testing issues when there is an inappropriate test conducted or no test conducted.

  • In 2016 PharmaTutor Edu Labs projected in its study of challenges report that there are 48% of companies that are not making any changes in their packaging and labeling process. Companies are using in-house systems that are harder for companies rather than outsourcing the artwork production. Adoption for automation and bringing change into the workflow requires a well-defined strategy.

Companies using in-house systems need to stay up to date with the latest regulatory changes and innovative technologies from the packaging and labelling sector. Some of the companies perform tests for other attributes such as texture analysis, visual inspection to save time and money. Excess testing also increases the cost to company and is wastage of time and resources of the manufacturers. Hence, testing issues act as a challenge for the pharmaceutical packaging testing equipment market.

Market Trends:

The global pharmaceutical packaging testing equipment market is segmented into two notable segments which are type and end-user.

  • On the basis of type, the market is segmented into services and equipment. In 2019, service segment is expected to dominate the global pharmaceutical packaging testing services market segment with 61.07% market share and also growing with the highest CAGR of 11.5% in the forecast period of 2019 to 2026.
  • Based on end user, the global pharmaceutical packaging testing equipment market is segmented into pharmaceutical companies, contract research organizations, government organizations, research institutions and testing laboratories. In 2019, the contract research organizations segment is expected to dominate the global pharmaceutical packaging testing services market segment with 35.51% market share and also growing with the highest CAGR of 12.6% in the forecast period of 2019 to 2026.

Major Players: Global Pharmaceutical Packaging Testing Equipment Market

Some of the major players operating in this market are LABTHINK, UNION PARK CAPITAL, WEST PHARMACEUTICAL SERVICES INC., Qualitest International Inc., AMETEK Sensors, Test & Calibration (STC), TEN-E, PTI Packaging Technologies and Inspection, AMRI, Westpak Inc., Eurofins Scientific, Intertek Group plc, Cryopak, SGS, TASI Group, Edwards Analytical, NSF International, Nelson Laboratories, LLC and others.